Biomea Fusion, Inc. (BMEA)
1.49
+0.05
(+3.47%)
USD |
NASDAQ |
Sep 24, 16:00
1.485
0.00 (0.00%)
After-Hours: 19:59
Biomea Fusion Price : 1.49 for Sept. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 24, 2026 | 1.46 | 1.50 | 1.39 | 1.49 | 2.185M |
| Sep 23, 2026 | 1.70 | 1.720 | 1.35 | 1.44 | 9.301M |
| Sep 22, 2026 | 1.71 | 1.78 | 1.66 | 1.70 | 2.337M |
| Sep 21, 2026 | 1.84 | 1.85 | 1.675 | 1.71 | 1.786M |
| Sep 18, 2026 | 1.79 | 1.93 | 1.770 | 1.83 | 1.631M |
| Sep 17, 2026 | 1.78 | 1.835 | 1.72 | 1.79 | 1.374M |
| Sep 16, 2026 | 1.80 | 1.835 | 1.705 | 1.74 | 1.596M |
| Sep 15, 2026 | 1.79 | 1.815 | 1.660 | 1.80 | 1.344M |
| Sep 14, 2026 | 1.715 | 1.79 | 1.66 | 1.78 | 1.552M |
| Sep 11, 2026 | 1.75 | 1.78 | 1.70 | 1.74 | 1.481M |
| Sep 10, 2026 | 1.83 | 1.84 | 1.68 | 1.70 | 2.501M |
| Sep 09, 2026 | 1.94 | 1.959 | 1.815 | 1.845 | 2.505M |
| Sep 08, 2026 | 2.00 | 2.07 | 1.89 | 1.93 | 1.853M |
| Sep 04, 2026 | 1.90 | 2.05 | 1.885 | 2.03 | 3.291M |
| Sep 03, 2026 | 1.93 | 1.98 | 1.84 | 1.91 | 1.759M |
| Sep 02, 2026 | 1.805 | 1.94 | 1.71 | 1.935 | 2.137M |
| Sep 01, 2026 | 1.68 | 1.87 | 1.671 | 1.80 | 2.267M |
| Aug 31, 2026 | 1.72 | 1.80 | 1.68 | 1.68 | 1.019M |
| Aug 28, 2026 | 1.69 | 1.745 | 1.650 | 1.73 | 1.168M |
| Aug 27, 2026 | 1.74 | 1.85 | 1.665 | 1.68 | 1.838M |
| Aug 26, 2026 | 1.755 | 1.83 | 1.65 | 1.71 | 3.219M |
| Aug 25, 2026 | 1.63 | 1.81 | 1.58 | 1.73 | 4.457M |
| Aug 24, 2026 | 1.51 | 1.77 | 1.495 | 1.59 | 11.50M |
| Aug 21, 2026 | 1.37 | 1.38 | 1.32 | 1.37 | 575261.0 |
| Aug 20, 2026 | 1.37 | 1.38 | 1.32 | 1.36 | 532473.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| REGENXBIO, Inc. | 7.24 |
| ACADIA Pharmaceuticals, Inc. | 22.18 |
| Alnylam Pharmaceuticals, Inc. | 249.59 |
| Anika Therapeutics, Inc. | 20.23 |
| Savara, Inc. | 5.07 |
Price Related Metrics
| Price to Book Value | 8.899 |
| Earnings Yield | -33.36% |
| Market Cap | 108.00M |